Erythromycin, a moderate inhibitor of cyp3a4, when administered at a dose of 500 mg four times a day for 4 days, affected the auc of reminyl prc minimally 10 increase .

Erythromycin and other macrolide antibiotics erythromycin is a moderately strong inhibitor of cyp3a4.